References
- Gerstein HC Miller ME Byington RP Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 2008 358 2545 2559 18539917
- Dluhy RG McMahon GT Intensive glycemic control in the ACCORD and ADVANCE trials N Engl J Med 2008 358 2630 2633 18539918
- Skyler JS Bergenstal R Bonow RO American Diabetes Association; American College of Cardiology Foundation; American Heart Association Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association Diabetes Care 2009 32 187 192 19092168
- Davis SN Mann S Briscoe VJ Ertl AC Tate DB Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes Diabetes 2009 58 701 709 19073776
- Cryer PE Axelrod L Grossman AB Evaluation and management of adult hypoglycemic disorders: An Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab 2009 94 709 728 19088155
- McCrimmon RJ Deary IJ Gold AE Symptoms reported during experimental hypoglycaemia: Effect of method of induction of hypoglycaemia and of diabetes per se Diabet Med 2003 20 507 509 12786691
- Briscoe VJ Davis SN Hypoglycemia in type 1 and type 2 diabetes: Physiology, pathophysiology and management Clin Diabetes 2006 24 115 121
- Bonds DE Miller ME Bergenstal RM The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study BMJ 2010 1 8 340 b4909 10.1136 20061358
- Miller ME Bonds DE Gerstein HC The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study BMJ 2010 8;340 b5444 10.1136/bmj.b5444
- Patel A MacMahon S Chalmers J ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 2008 358 2560 2572 18539916
- Desouza C Salazar H Cheong B Murgo J Fonseca V Association of hypoglycemia and cardiac ischemia: A study based on continuous monitoring Diabetes Care 2003 26 1485 1489 12716809
- Van den Berghe G Wilmer A Hermans G Intensive insulin therapy in the medical ICU N Engl J Med 2006 354 449 461 16452557
- Mellbin LG Malmberg K Waldenstrom A Wedel H Ryden L DIGAMI 2 Investigators Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: A report from the DIGAMI 2 trial Heart 2009 95 721 727 19029171
- Whitmer RA Karter AJ Yaffe K Quesenberry CPJr Selby JV Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus JAMA 2009 301 1565 1572 19366776
- American Diabetes Association Standards of medical care in diabetes – 2009 Diabetes Care 2009 32 Suppl 1 S13 S61 19118286
- Rodbard HW Jellinger PS Davidson JA Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An algorithm for glycemic control Endocr Pract 2009 15 540 559 19858063
- National Institute for Health and Clinical Excellence 2009 Type 2 diabetes: Newer agents for blood glucose control in type 2 diabetes Available at: http://www.nice.org.uk/nicemedia/pdf/CG87ShortGuideline.pdf Accessed September 30, 2009
- Nathan DM Buse JB Davidson MB Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 2009 32 193 203 18945920
- Glucophage [package insert] Princeton, NJ Bristol-Myers Squibb 2009
- Drucker DJ Buse JB Taylor K DURATION-1 Study Group Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: A randomised, open-label, non-inferiority study Lancet 2008 372 1240 1250 18782641